About Us

Innovators. Dreamers.

Demand for affordable high-quality COVID-19 antibody ELISA diagnostics is increasing worldwide. To answer this demand; BioArtron Diagnostics Inc. decide to start its new venture in the industry.                                                                                
With Artron over 10 years successful R&D development on rapid  Immunoassay antibodies and finished test kits, and experience on building brand recognition and market share, Artron is able to support BioArtron to bring innovative solutions, production, marketing and sales of Immunoassay analyzer and reagents to the industry.